A Randomized, Placebo-Controlled Study of Galcanezumab in Patients with Treatment-Resistant Migraine: Double-Blind Results from the CONQUER Study (162)
Wim M. Mulleners, Byung‐Kun Kim, Miguel J. A. Láinez, Michel Lantéri‐Minet, Sheena K. Aurora, Russell Nichols, Shufang Wang, Antje Tockhorn‐Heidenreich, Holland C. Detke
Abstract
CONQUER assessed galcanezumab efficacy and safety in patients with migraine who had not benefited from multiple previous migraine preventive treatments.
Topics & Concepts
MigrainePlaceboDivide and conquer algorithmsMedicineDouble blind studyInternal medicineDouble blindComputer scienceAlternative medicinePathologyAlgorithmMigraine and Headache Studies